SPRI | Translational Neuropsychopharmacology (2016 EN)

Discussion in 'Medicine' started by Kanka, Sep 10, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,037
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Trevor W. Robbins (Editor), Barbara J. Sahakian (Editor)
    Full Title: Translational Neuropsychopharmacology
    Publisher: Springer; 1st ed. 2016 edition (May 26, 2016)
    Year: 2016
    ISBN-13: 9783319339139 (978-3-319-33913-9), 9783319339115 (978-3-319-33911-5)
    ISBN-10: 3319339133, 3319339117
    Pages: 498
    Language: English
    Genre: Biomedical Sciences: Neuroscience
    File type: PDF (True)
    Quality: 10/10
    Price: 181.89 €


    This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.

    -------------
     
    Last edited by a moderator: Nov 26, 2019